Vimarsana
Biggest News Aggregation in the World

Page 2 - Allogeneic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allogeneic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allogeneic Today - Breaking & Trending Today

Affimed Announces Acceptance of Abstracts at the 17th International Conference on Malignant Lymphoma (17-ICML) - Vimarsana News

Affimed Announces Acceptance of Abstracts at the 17th International Conference on Malignant Lymphoma (17-ICML)

A pre-clinical data set of AFM13 in combination with Artiva Biotherapeutics Inc.’s allogeneic NK cell AB-101 shows that AFM13 enhances the cytotoxic activity of AB-101 against tumor cells and... | June 9, 2023

Cellectis Presents Updated Clinical and Translational Data - Vimarsana News

Cellectis Presents Updated Clinical and Translational Data

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company...

Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference - Vimarsana News

Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and... | June 7, 2023

Precision BioSciences to Present at Upcoming June Investor Conferences - Vimarsana News

Precision BioSciences to Present at Upcoming June Investor Conferences

Precision BioSciences, Inc. a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that members of management... | June 5, 2023

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B cell Lymphoma at the American Society of Clinical Oncology Annual Meeting - Vimarsana News

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B cell Lymphoma at the American Society of Clinical Oncology Annual Meeting

SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, today presented long-term follow up... | June 5, 2023